Evidence map›Paper›PMID 26672736›Full record

Observational studyPediatric research2016

Serum hepcidin in infants born after 32 to 37 wk of gestational age.

Lieke Uijterschout, Magnus Domellöf, Staffan K Berglund, Micky Abbink, Paul Vos, Lyanne Rövekamp, Bart Boersma, Carina Lagerqvist, Cisca Hudig, Johannes B van Goudoever and 1 more

Open access · bronzeAbstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Pediatric research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Serum erythroferrone levels during the first month of life in premature infants.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Lieke UijterschoutDepartment of Pediatrics, OLVG, Amsterdam, the Netherlands.
Magnus DomellöfDepartment of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
Staffan K BerglundDepartment of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
Micky AbbinkDepartment of Pediatrics, Medical Center Alkmaar, Alkmaar, The Netherlands.
Paul VosDepartment of Pediatrics, Medical Center Haaglanden, The Hague, The Netherlands.
Lyanne RövekampDepartment of Pediatrics, VU University Medical Center, Amsterdam, the Netherlands.
Bart BoersmaDepartment of Pediatrics, Medical Center Alkmaar, Alkmaar, The Netherlands.
Carina LagerqvistDepartment of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
Cisca HudigDepartment of Clinical Chemistry, LabWest, HAGA Teaching Hospital, The Hague, The Netherlands.
Johannes B van GoudoeverDepartment of Pediatrics, VU University Medical Center, Amsterdam, the Netherlands.
Frank BrusDepartment of Pediatrics, VU University Medical Center, Amsterdam, the Netherlands.
Amsterdam UMC Location VUmc · NLUmeå University · SEMedisch Centrum Alkmaar · NLHaga Hospital · NLMedisch Centrum Haaglanden · NLOLVG · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreterm infants are at risk of iron deficiency (ID). Hepcidin has been suggested as a good additional indicator of ID in preterm infants, next to ferritin.

methodsIn a prospective observational study, we analyzed serum hepcidin in 111 infants born after 32+0 to 36+6 wk gestational age during the first 4 mo of life.

resultsHepcidin concentrations decreased during the first 4 mo of life, and concentrations were lower in infants with ID compared to those without ID. Infants who developed ID at the age of 4 mo had already significantly lower levels of hepcidin at 1.5 mo of age, while ferritin was already significantly lower at the age of 1 wk.

conclusionHepcidin concentrations of late preterm infants decrease during the first 4 mo of life. This decrease, which parallels a decrease of ferritin concentration, we interpret as a physiological response, aiming to increase iron availability. Hepcidin concentrations are lower in infants with ID compared with those without ID, with a notable change already observed at 1.5 mo of age. Hepcidin can be used as an early marker of ID, although an additive value of hepcidin over ferritin in the diagnosis of ID is not present.

Indexed as

Infant, PrematureBiomarkersFemaleHepcidinsHumansInfantInfant, NewbornMaleProspective StudiesBiomarkersHepcidins

Identifiers

PMID26672736
OpenAlexW2264988736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.